Running Oak Capital
RMD icon

Running Oak Capital’s ResMed RMD Stock Holding History

Running Oak Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.3M Buy
50,994
+9,686
+23% +$2.11M 1.86% 16
2026
Q2 		$8.05M Sell
41,308
-16,489
-29% -$3.42M 1.37% 52
2026
Q1 		$13M Sell
57,797
-3,028
-5% -$755K 1.75% 37
2025
Q4 		$14.7M Sell
60,825
-2,683
-4% -$686K 1.84% 29
2025
Q3 		$17.4M Sell
63,508
-2,453
-4% -$670K 1.95% 14
2025
Q2 		$17M Sell
65,961
-1,883
-3% -$449K 1.89% 16
2025
Q1 		$15.2M Buy
+67,844
New +$15.8M 1.83% 33

Other funds holding RMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Running Oak Capital's RMD Position: Q3 2026 in Review

Running Oak Capital increased its ResMed (RMD) stake by 23% in Q3 2026, buying an estimated $2.11M and bringing the position to 50,994 shares worth $11.3M. The position accounts for 1.86% of the portfolio, ranked #16.

Running Oak Capital first reported a position in RMD in Q1 2025 and has held it in 7 quarters since. The position peaked at $17.4M in Q3 2025. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Running Oak Capital held 50,994 shares of ResMed worth $11.3M as of Q3 2026.
  • Running Oak Capital bought 9,686 ResMed shares in Q3 2026, an estimated $2.11M.
  • ResMed made up 1.86% of Running Oak Capital's portfolio in Q3 2026, its #16 holding.
  • Running Oak Capital first reported a position in ResMed in Q1 2025 and has held it in 7 quarters since.
  • Running Oak Capital's ResMed position peaked at $17.4M in Q3 2025.
  • 535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Running Oak Capital's 13F filing for Q3 2026, filed 4 Nov 2026.